What is the main business of Surgical Planning Solutions?

The main business activity of Surgical Planning Solutions focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 9, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Maszewska 3A, 01-925 Warszawa.

Who is on the management board?

The management board consists of: Andrzej Mioduszewski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $0.

Is the company profitable?

Yes, the company recorded a net profit of $0 in 2024.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $30 in 2024, representing 100% of all operating expenses.

Surgical Planning Solutionssp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2019-10-09

Share capital

10,000.00 PLN

Registered address

ul. Maszewska 3A, 01-925 Warszawa, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

5 of 6 financial statements were filed late (the longest delay 1379 days for 2020).

202513/07/2026
202425/07/2025
202325/07/2025
202225/07/2025
202125/07/2025
202025/07/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Andrzej Mioduszewski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Andrzej Mioduszewskiage 59	100	$2,701.24	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2019-11-29 to 2026-09-15.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
FamicordtxS.A.	$1,365,068.41	famicordtx.com
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
Explorna Therapeuticssp. z o.o.	$304,662.00	explorna.com
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
ModicaP.S.A.	$103,400.72	modica.bio
Bioselsp. z o.o.	$19,100.32	selol.pl
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
LASTsp. z o.o.	–	last-skincare.com
Nawah Scientific Polandsp. z o.o.	–	nawah-scientific.com

Change history

Date	Event
2025-08-25	Business suspended
2025-05-27	Business resumed
2020-03-24	Business suspended
2019-10-09	Entered in the register

FAQ

Last updated: 2026-10-07